TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) issued its quarterly earnings results on Thursday. Here are the key takeaways from TriSalus Life Sciences’ conference call:Get TriSalus Life Sciences alerts:Q2 revenue reached $11.4 million , up sequentially and 1.7% year over year, while gross margin improved to 86.8% from 83.9% due to lower unit costs and manufacturing improvements. TriSalus Life Sciences Trading Up 15.2%TriSalus Life Sciences stock traded up $0.74 during mid-day trading on Friday, hitting $5.61. TriSalus Life Sciences has a 12 month low of $2.20 and a 12 month high of $7.95. See AlsoReceive News & Ratings for TriSalus Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriSalus Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.